SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $836,418 | +5.9% | 6,900 | 0.0% | 0.13% | +11.4% |
| Q2 2023 | $790,188 | -16.9% | 6,900 | 0.0% | 0.11% | -22.4% |
| Q1 2023 | $951,027 | +6.4% | 6,900 | 0.0% | 0.15% | +1.4% |
| Q4 2022 | $894,102 | +17.2% | 6,900 | 0.0% | 0.14% | +10.7% |
| Q3 2022 | $763,000 | +67.3% | 6,900 | +130.0% | 0.13% | +59.8% |
| Q2 2019 | $456,000 | +91.6% | 3,000 | +50.0% | 0.08% | +90.7% |
| Q1 2019 | $238,000 | -27.2% | 2,000 | -33.3% | 0.04% | -36.8% |
| Q4 2018 | $327,000 | -32.6% | 3,000 | 0.0% | 0.07% | -18.1% |
| Q3 2018 | $485,000 | +83.7% | 3,000 | +50.0% | 0.08% | +76.6% |
| Q2 2018 | $264,000 | – | 2,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 1,195,000 | $142,432,000 | 6.16% |
| Casdin Capital, LLC | 305,000 | $36,353,000 | 3.99% |
| Eventide Asset Management | 845,168 | $100,736,000 | 3.47% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 436,000 | $51,967,000 | 3.26% |
| NEXTHERA CAPITAL LP | 21,270 | $2,535,000 | 3.08% |
| Camber Capital Management LP | 500,000 | $59,595,000 | 2.97% |
| Eversept Partners, LP | 83,574 | $9,961,185 | 2.91% |
| CADIAN CAPITAL MANAGEMENT, LP | 610,546 | $72,771,000 | 2.84% |
| RTW INVESTMENTS, LP | 338,199 | $40,310,000 | 2.75% |
| Cormorant Asset Management, LP | 300,000 | $35,757,000 | 2.42% |